Table 3.

Invasive cancer versus benign without atypia

TrainingValidation
MarkerAUCPaInvertbAUCP
CEA0.6150.012920.510.82743
CA 1250.5860.062250.5670.14861
PPP2R40.6330.00375Yes0.5080.86407
RAC10.610.01718Yes0.530.51718
Sclerostin0.6070.02106Yes0.5670.1496
IL12 p700.6040.024160.540.38493
IL20.6040.023850.5830.07337
  • aAll markers with unadjusted P values less than 0.05 in the training phase are shown.

  • bIf “yes,” then the values were higher in the controls compared with cases.